ESPERANZA: External Control Arm Study for T-DXd for Patients With HER2 IHC3+ Solid Tumors
AstraZeneca
AstraZeneca
Servier
Zumutor Biologics Inc.
Amgen
Sotio Biotech Inc.
SystImmune Inc.
AstraZeneca
Myeloid Therapeutics
DualityBio Inc.
Boehringer Ingelheim
Seagen Inc.
NextCure, Inc.
Tanabe Pharma America, Inc.
AstraZeneca
Bayer
Eli Lilly and Company
Merck Sharp & Dohme LLC
Bolt Biotherapeutics, Inc.
Yuhan Corporation
Bristol-Myers Squibb
Marengo Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
TransThera Sciences (Nanjing), Inc.
Black Diamond Therapeutics, Inc.
Evopoint Biosciences Inc.
Carisma Therapeutics Inc
Vincerx Pharma, Inc.
Rain Oncology Inc
Taiho Pharmaceutical Co., Ltd.
Eli Lilly and Company
GeneQuantum Healthcare (Suzhou) Co., Ltd.
Cantargia AB
Ambrx, Inc.
Silverback Therapeutics
AstraZeneca
GlaxoSmithKline
Mannkind Corporation